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MICROVASCULAR OSCILLATIONS ELICITED LOCALLY BY COMBINED IONTOPHORESIS OF 
PHENYLEPHRINE AND ACUPRESSURE. Frederick C. Lewis, Michael Scanned, Julie Park, and David 
G. Silverman. Department of Anesthesiology, Yale University School of Medicine, New Haven, CT. 
This study tested the hypothesis that organized vasomotion of the peripheral microvasculature 
consistent with cholinergic oscillatory control could be elicited by local iontophoresis of phenylephrine and 
that the response would be enhanced by acupressure at the Lung point of the ear (a method known to 
increase vagal tone). 
Heart rate, respiration, and forehead flow (via a 1mm2 laser Doppler surface probe) were 
monitored in 8 healthy volunteers. Forehead flow was measured at three sites receiving iontophoresed 
phenylephrine, iontophoresed normal saline (NS), or no iontophoresis (control site), respectively. 
Volunteers received iontophoresis for an average of 30 seconds, followed by a ten-minute rest period, then 
bilateral ear acupressure for two minutes. 
The phenylephrine site showed a 25% reduction in flow following iontophoresis (p<0.01 using a 
paired t test), while iontophoresis induced no significant change in flow at the NS or control sites. During 
the period of ear acupressure, the phenylephrine site showed an increase in the amplitude and organization 
of oscillatory activity as documented by an increase in intermediate-frequency (IF, 0.12-0.18 Hz) spectral 
power when compared with the other two forehead sites and with the phenylephrine site at baseline (p<0.01 
for all comparisons). This increase in forehead oscillatory power, which is consistent with parasympathetic 
but not sympathetic oscillatory activity, was independent of respiration and of the major oscillatory power 
of the ECG. No obvious or consistent change occurred in heart rate, standard deviation of heart rate, or 
heart rate oscillatory power in the IF range, suggesting that there was no systemic effect from either the 
phenylephrine or the acupressure. 
These findings indicate that IF microvascular oscillations can be elicited by local iontophoresis of 
phenylephrine in combination with enhancement of vagal tone by acupressure. The study provides a model 
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The existence of rhythmic variations in biological systems has been recognized for 
centuries. Oscillations in cardiovascular variables such as heart rate and blood pressure have 
been appreciated since at least 1733, when Stephen Hales noted beat-to-beat variations in these 
variables while performing the first quantitative measurements of arterial blood pressure. Since 
then, many others have described variability in heart rate and blood pressure (1,2). More 
recently, quantification of these variations has been performed using computer techniques such as 
power spectral analysis (3,4,5), with the most common of these techniques being Fourier analysis. 
The fast Fourier transformation (FFT), a computer approximation of the original Fourier Series, 
allows for the quantification of repeating signals in biological systems over a range of 
frequencies. 
Using the technique of FFT, investigators have identified several discrete frequency 
bands which account for the majority of variability in heart rate and blood pressure. Low- 
frequency (LF) fluctuations, below 0.12 Hz, are jointly mediated by the sympathetic and 
parasympathetic nervous systems (5,6). High-frequency (HF) fluctuations, in the range of 
0.12-0.30 Hz, are mediated solely by the parasympathetic nervous system, as evidenced by their 
elimination with atropine but not by propranolol (6,7). Additionally, the sympathetic nervous 
system is believed to be incapable of mediating fluctuations at frequencies higher than 0.12 Hz 
because of the complex second-messenger system involved in adrenergic transmission (8). 
A portion of the high frequency component of heart rate and blood pressure variability 
has been ascribed to vagally mediated changes which occur at the heart in synchrony with 
respiration. Inspiration produces negative intrathoracic pressure and decreased pulmonary 
vascular resistance, which in turn lead to increased venous return to the heart and increased stroke 
volume. The inspiratory decrease in thoracic pressure also leads to an acceleration of heart rate 
due to a parasympathetic withdrawal triggered by baroreceptor unloading (9). High-frequency 
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variability in blood pressure, rather than representing fluctuations in vagal efferent activity to the 
smooth muscles of the vasculature, is thought to result from changes in stroke volume influenced 
by the status of the respiratory cycle and its effect on venous return (10). Thus cycles of heart 
rate acceleration and increased stroke volume occur with each inspiratory phase, setting them 
equal to the respiratory frequency. Therefore, assuming a person is breathing at a rate of at least 
12 breaths per minute, the high-frequency range of fluctuations can be further subdivided into 
intermediate-frequency (IF, 0.12-0.18 Hz) and respiratory frequency (RF, 0.18-0.30 Hz) bands. 
In addition to heart rate and blood pressure variability, rhythmic variation has also been 
demonstrated in the diameters of small arteries, arterioles, and venules. Termed vasomotion, this 
phenomenon was described by Nicoll and Webb based on their microscopic observation of bat 
wings (31,12). Fagrell and colleagues later discovered this oscillatory activity in the 
microvasculature of human skin by using video microscopy, positioning two small 
videophotometric windows along a monitored capillary (13). In the early 1980s the technique of 
laser Doppler flowmetry made possible the noninvasive continuous monitoring of microvascular 
blood flow in skin (14,15,16). Laser Doppler flowmetry monitors flow in the 10-60 capillaries 
500-700 nm below the skin surface by detecting frequency shifts of laser light as it is deflected by 
moving red blood cells in the capillaries under a 1 -mm2 surface probe. The standard laser 
Doppler output is red blood cell (RBC) flux, or the product of the number of moving RBCs in the 
microcirculatory vessels under the probe (i.e., the number that cause a Doppler shift) and their 
velocities (i.e., the magnitude of the shift). However, the vessels in which the flux is measured 
are predominantly capillaries and postcapillary venules of the upper horizontal plexus which 
exhibit little change in vessel diameter. Therefore, oscillations in laser Doppler flux are ascribed 
to propagation of oscillatory activity in the smooth muscle of precapillary sphincters upstream of 
the capillary bed (17). 
Although the physiological role that vasomotion serves is uncertain, one of the most 
compelling theories is that it may help to direct blood flow to certain body regions. Poiseuille’s 
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law states that the resistance of a vessel is inversely proportional to the fourth power of the 
vessel’s diameter. Wilkin points out that “the resistance of a vessel with constant diameter is 
notably greater than that of a vessel with the same average diameter in which the diameter 
changes sinusoidally” (18). Thus oscillations, by creating over time a decreased vascular 
resistance, may be a physiological mechanism for redirecting blood flow or even for 
compensating for a state of relative ischemia. 
By combining laser Doppler flowmetry with power spectral analysis, researchers have 
quantified the frequencies of microvascular oscillations (10,19,20,21). Furthermore, investigators 
have demonstrated that, similar to heart rate and blood pressure periodicity, different frequency 
ranges of microvascular oscillations appear to correlate with varying degrees of sympathetic and 
parasympathetic mediation. 
The origin of microvascular oscillations is unknown and may be multifactorial. Nicoll 
and Webb described vasomotion as the inherent property of vascular smooth muscle cells to 
exhibit spontaneous contractions (11). Several researchers believe that this steady state of 
“background” oscillatory activity can be altered by local metabolic demands (22,23,24). Siegel 
proposed a biochemical explanation for the rhythmicity of vascular smooth muscle based on the 
kinetics of the allosteric enzyme phosphofructokinase (25). Applying known enzyme kinetics 
and tissue concentrations, he described a pathway through which changing substrate 
concentrations could cause varying activity of the enzyme, leading to oscillations in glycolysis 
and ultimately to oscillations in membrane potential and cell contractility. Wilkin demonstrated 
that microvascular oscillations at 0.1 Hz are particularly prominent during the period of recovery 
from postocclusive reactive hyperemia and aldehyde-induced hyperemia (18). Citing the 
biochemical pathway described by Siegel as the source of the oscillations, Wilkin proposed that 
the stimulus for oscillations in both cases is the physical or pharmacologic stretch of myogenic 
cells. Following this stimulus, the oscillations become most prominent during the return from 

vasodilation (accompanied by hyperpolarization of smooth muscle cells) to resting sympathetic 
vasoconstrictor tone. 
4 
Other theories on the source of microvascular oscillations account for autonomic 
regulation of the microvasculature. LF oscillations (<0.12 Flz) are considered to be a marker of 
sympathetic activity in heart rate and blood pressure. At the microvascular level, Bernardi and 
colleagues demonstrated that skin blood flow oscillations at 0.1 Flz could be enhanced by 
maneuvers (such as tilting) which increase sympathetic tone and blunted by pharmacologic 
sympathectomy (20). As with heart rate and blood pressure, HF microvascular oscillations 
(>0.12 Hz) are thought to represent purely parasympathetic influence because the sympathetic 
nervous system’s second-messenger system makes it incapable of transmitting signals at these 
higher frequencies (8). The respiratory frequency is known to account for a portion of the HF 
range microvascular oscillations via mechanical transmission of variations in cardiac stroke 
volume, in the same manner as discussed above for the respiratory influence on blood pressure 
variability. 
Using the squared coherence function, Bemardi et al. measured the correlation between 
oscillations in skin blood flow of the finger and oscillations in blood pressure and heart rate (10). 
The squared coherence function, a type of bivariate analysis, allows determination of whether two 
signals oscillating at the same frequency maintain a stable phase relationship. They discovered 
that HF oscillations in blood pressure and heart rate precede those in the skin blood flow, 
indicating that these oscillations in the microvasculature reflect downstream transmission of 
vagally mediated fluctuations in cardiac tone. By contrast, LF oscillations were found to 
originate in the skin, as they preceded these same oscillations in blood pressure and heart rate. 
Several additional observations are consistent with the theory of autonomic influence of 
microvascular oscillations. Mevio and Bemardi compared skin blood flow oscillations in the 
forearm and nasal mucosa using laser Doppler flowmetry (26). The nasal mucosa is known to 
have rich autonomic innervation, both sympathetic and parasympathetic, whereas the innervation 
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of forearm skin vessels, while mixed, is more sympathetic than parasympathetic. The 
investigators found that increasing the respiratory frequency—and thereby the overall frequency 
of any parasympathetic component—caused an increase in oscillatory frequency of blood flow in 
the nasal mucosa but not in the forearm skin. They also discovered that the tilt test maneuver 
(which is known to be a sympathetic stimulus) caused a significantly larger decrease in blood 
flow oscillatory frequency in the nasal mucosa than in the forearm skin, suggesting that the 
parasympathetic relative to sympathetic innervation is greater in the nasal mucosa vasculature 
than in that of forearm skin. Furthermore, when Salerud and colleagues measured oscillatory 
frequencies at multiple sites in one subject, they found frequencies in the forehead, upper arm, 
forearm, and foot of 10.0, 7.2, 6.3, and 5.6 cycles per minute, respectively. The finding of higher 
oscillatory frequencies proximally is consistent with the known higher ratio of parasympathetic to 
sympathetic innervation at more central regions of the body. 
In a further study of cutaneous laser Doppler flowmetry, Silverman and colleagues 
measured the RBC flux at the volar forearm and the palmar surface of the finger at baseline and 
after systemic infusion of phenylephrine (27). As expected, the laser Doppler flux decreased at 
the finger site following phenylephrine administration. However, flux values in the forearm 
increased during the infusion, suggesting a potential homeostatic response to increased plasma 
concentrations of an oti-receptor agonist. While the vessels of both the finger and forearm are 
known to be richly innervated with adrenoceptors, the forearm skin vessels are also under 
cholinergic regulation (28,29,30,31). Additionally, the increase in flux seen in the forearm was 
consistent with vagally mediated baroreceptor responses noted in other settings, such as carotid 
sinus stretch and body tilting (32,33). Furthermore, the homeostatic nature of the vagal response 
to infused phenylephrine was demonstrated by the finding that the pressure increase induced by 
phenylephrine was markedly increased after vagal block with atropine (34). Thus it was 
reasonable to hypothesize that the disparity between finger and forearm reaction to an dj-agonist 

was due to a cholinergically mediated homeostatic response in the microvasculature of the 
forearm. 
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Based on the results of this study and the knowledge that cholinergic activity is primarily 
responsible for oscillations in heart rate (heart rate variability), Silverman and colleagues next 
hypothesized that cholinergic activity might induce oscillations in the microvasculature which 
might be activated in the presence of a vasoconstrictive stimulus (35). To investigate this 
hypothesis, they used laser Doppler flowmetry to measure flux in the forehead and the palmar 
surface of the finger at baseline and after intravenous infusion of phenylephrine. In the forehead, 
the average flux remained constant during the infusion and developed prominent oscillations in 
the IF range (0.12-0.18 Hz). The cholinergic nature of these oscillations was confirmed by their 
ablation upon intravenous administration of atropine. LF oscillatory power did not change during 
any phase of the study. By contrast, finger flux decreased by 50% during phenylephrine infusion 
and did not exhibit IF oscillations. The investigators concluded that the IF oscillations of the 
forehead microvasculature were consistent with cholinergic oscillatory control. 
Although these findings suggest a cholinergic parasympathetic control of the vasculature, 
traditionally autonomic regulation of the peripheral vasculature is believed to be almost entirely 
sympathetic. Aside from its role in “local functional hyperemia” (36) such as the erectile system 
of the penis, acetylcholine (ACh) has been considered an “outcast as a vasomotor transmitter” 
(36), and the parasympathetic nervous system is viewed as having “virtually no effect on 
peripheral resistance” (37). This belief persists despite the identification of ACh receptors in 
vessel walls (36,38), ACh-induced vasodilation upon iontophoretic delivery or continuous 
infusion (39,40), and evidence of a parasympathetic vasodilator mechanism in the lower gingiva 
of cats (41). Nevertheless, the traditional consensus as to the lack of physiologically relevant 
cholinergically mediated vasomotion suggests that these IF oscillations do not originate in the 
microvasculature, but rather represent the downstream transmission of oscillations in cardiac 
stroke volume in response to a vagomimetic challenge and thus would be transmitted via pressure 
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and flow waves to the periphery in a manner similar to the transmission of respiratory-induced 
fluctuations in heart rate and blood pressure. Therefore, in order to suggest that these oscillations 
represent a local parasympathetic control of the microvasculature, it is necessary to document a 
lack of association between cholinergic oscillatory control at the heart and at the 
microvasculature. 
To demonstrate this lack of association, Silverman and colleagues measured laser 
Doppler flux in the forehead and ventral forefinger of eight subjects first at baseline and then 
during the infusion of phenylephrine to achieve a 50% decline in finger flux (42). Throughout 
the study subjects breathed in time to a metronome at 12 breaths/minute (0.20 Hz) to fix the 
frequency of respiratory oscillations. Although there was the anticipated baroreceptor-mediated 
decline (10-15%) in heart rate with phenylephrine infusion, there was no significant change in the 
magnitude of heart rate oscillations, which persisted at the respiratory frequency during both the 
baseline and infusion phases. In contrast, the forehead flux developed increased oscillations 
during the infusion phase, with a unique peak at approximately 0.14 Hz. Both the heart rate and 
the forehead flux oscillations were eliminated by the infusion of atropine, confirming their 
cholinergic nature. Additionally, continuous monitoring of blood pressure via a finger 
plethysmographic technique in several subjects confirmed that the oscillations in forehead flux 
occurred at a frequency distinct from that of systemic blood pressure. Furthermore, the 
simultaneous use of multiple forehead laser Doppler probes revealed that the oscillations at 
different forehead sites were not necessarily in phase with one another, indicating that the 
oscillatory control was at the level of the microvasculature rather than at a central location which 
would have coordinated the oscillations at the different sites. The peripheral mediation of the 
phenylephrine-induced oscillations was further confirmed by their elimination by topical 
application of a eutectic mixture of local anesthetic. 
These observed cholinergically mediated oscillations during infusion of an oti-agonist are 
consistent with reports of ACh-induced release of nitric oxide in response to changes in 
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intraluminal pressure (43,44). Indeed, nitric oxide has been observed to “limit the work of 
perfusion... by coordinating the behavior of resistance vessels” (45). In addition, the 5-10 second 
half-life of nitric oxide is consistent with the period of the HF oscillations. A homeostatic 
process such as the described cholinergic oscillatory control would help explain the observations 
that subcutaneous injection of phenylephrine does not cause local blanching (46) and that 
addition of vasoconstrictive drugs to an in vitro vessel preparation induces an endothelium- 
dependent compensatory vasodilatory response (47). Although there appears to be local control 
of this oscillatory response based on the above study by Silverman and colleagues, it is unclear 
whether the entire pathway mediating the oscillations is confined to the microvasculature or 
whether there is a hierarchical control system similar to that of the smooth muscle of the 
gastrointestinal tract, which is under both local and vagal control. 
A microvascular homeostatic oscillatory mechanism may have special significance in 
certain cardiovascular disease states. The addition of ACh to in vitro vessel preparations causes 
vasodilation even in the context of vasoconstrictive drugs, but this ability to dilate is lost in the 
presence of endothelial injury (47,48). Diabetic autonomic neuropathy and hypertension are both 
associated with loss of autonomic activity and development of endothelial injury, and several 
studies have examined changes in oscillatory behavior at both the central (i.e., heart rate and 
blood pressure) and microvascular level in patients with these diseases. 
In a study of hypertensive patients being tilted from supine to upright, the LF component 
of heart rate fluctuations increased and the HF component decreased much less in hypertensive 
subjects than in the control group, and the LF components of skin blood flow increased only in 
control subjects (49). These findings suggest sympathetic and parasympathetic impairment in 
hypertensive subjects. 
Multiple studies have demonstrated impairment of sympathetic-range vasomotion in 
diabetics. Stansberry and colleagues found the amplitude of very low-frequency vasomotion (1-2 
cycles per minute) to be much lower in diabetic patients than in control subjects and that this 
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decreased vasomotor amplitude also correlated with loss of function of thinly myelinated C-fibers 
(50). Bemardi and colleagues found the power of 0.1 Hz microcirculatory fluctuations to be 
significantly lower in diabetic than in control subjects (51). Aso and colleagues discovered that 
the vasoconstrictor response (measured in the big toe) to deep inspiration (which is known to 
elicit vasoconstrictive effects) was significantly decreased in diabetic patients compared with 
healthy subjects (52). Furthermore, in diabetic patients the vasoconstrictor response was 
negatively correlated with the duration of diabetes, the median motor and sensory nerve 
conduction velocities, resting heart rate variability, and postural fall in systolic blood pressure. 
Other studies have examined dysfunction in cholinergic and parasympathetic activity in 
diabetics. Bemardi and colleagues found an absence of power in the HF band of the heart rate 
variability power spectrum in diabetic patients (53). In addition, loss of HF oscillatory activity in 
heart rate and blood pressure in diabetics was found to be associated with poor wound healing 
(54). Morris and colleagues found the vasodilatory effects of both acetylcholine and sodium 
nitroprusside (a nitric oxide donor) to be attenuated in diabetic patients compared with healthy 
controls, suggesting that endothelial and/or smooth muscle function may be impaired in the skin 
microcirculation of diabetic patients (55). Given the evidence that diabetic patients have both 
impaired centrally mediated parasympathetic oscillations and attenuated cholinergically mediated 
vasodilation, it is reasonable to suspect that they may also have a dysfunction of parasympathetic 
frequency-range oscillations at the microvascular level. 
If microvascular cholinergic oscillatory control serves a homeostatic function that is 
impaired in patients with cardiovascular disease, it would be useful to have a method of testing 
this function in patients at risk for developing these diseases before they show clinical signs of 
impairment. In fact, there is mounting evidence that such autonomic impairment precedes 
clinical signs. The diabetic patients found in Bemardi’s study to have decreased sympathetic- 
range microcirculatory fluctuations had no clinical symptoms of autonomic dysfunction (51); Aso 
and colleagues’ study showing that diabetics had decreased vasomotor reflexes in response to 
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deep inspiration was performed on diabetic patients without peripheral vascular disease or 
evidence of autonomic dysfunction (52). These findings, coupled with evidence that sympathetic 
nerve failure in diabetics occurs earlier than previously thought (56), suggest not only that 
microvascular oscillatory dysfunction may contribute to the pathogenesis of these diseases, but 
also that its early detection may help in the diagnosis and treatment of patients at risk for 
cardiovascular disease. 
As mentioned previously, it is unclear whether the entire pathway mediating IF 
microvascular oscillations is confined to the vasculature or whether there may be a hierarchical 
control involving more proximal regulation. To address this question, a method of eliciting the IF 
microvascular oscillations previously seen on phenylephrine infusion was sought that could be 
both performed and measured at a local level. Such a method would ideally be as noninvasive as 
possible to avoid activating local pain pathways which could affect blood flow and interfere with 
or prevent the oscillations. A review of the literature suggested that the least invasive means of 
administering phenylephrine locally is via iontophoresis. 
Iontophoresis is a technique which uses small, physiologically safe amounts of electric 
current to administer soluble chemicals and drugs to a small surface region of the body such as 
the finger, forearm, or forehead. By using an electrode of the same polarity as the charge of the 
drug, the drug is driven into the skin by electrostatic repulsion in a quantity proportional to the 
current applied. This technique avoids the pain and tissue disruption associated with needle 
injection and the potential effects of systemic drug administration. Iontophoresis has found 
widespread clinical applications in dermatology (57,58) and is also used in physical therapy, 
primarily for the delivery of lidocaine and dexamethasone (60). The Department of Pediatrics at 
our own institution regularly uses a commercially available iontophoresis system to deliver a 
solution of lidocaine HC1 2% + epinephrine 1:100,000 prior to placement of intravenous catheters 
(Iomed, Inc., Salt Lake City, Utah). 
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Several investigators have already shown that a wide variety of drugs, including 
norepinephrine, phenylephrine, acetylcholine, atropine, lidocaine, and nitroprusside have been 
administered safely and effectively by iontophoresis (28,60,61,62,63,64). Indeed, phenylephrine 
and norepinephrine administered iontophoretically induce local vasoconstriction (63), while 
acetylcholine and nitroprusside cause the anticipated vasodilatation (62). However, these studies 
measured changes in overall flow which were produced by iontophoresis of drugs, rather than 
measuring changes in microvascular oscillatory patterns. 
While awaiting the delivery of a suitable iontophoresis system, our research team tested 
subcutaneous injection of phenylephrine as a potential local delivery method. Using a 24-gauge 
needle, 0.1 ml of phenylephrine 1:25,000 was injected subcutaneously at a site on the forehead, 
and 0.1 ml of normal saline was injected subcutaneously at a different forehead site. Preliminary 
results indicated the occurrence of vasoconstriction and the development of IF oscillatory activity 
at the phenylephrine site almost immediately after injection. However, the injection was found to 
produce a wheal at the skin surface which may have caused local compression of blood flow and 
may have altered the distance from the laser Doppler probe to the capillary bed in which flow was 
being measured. Therefore, comparison of laser Doppler readings before and after injection may 
have been unreliable. Additionally, the injection of drug was found by multiple subjects to be 
painful. Thus there was the possibility of activation of a local pain reflex, with release of 
histamine and other vasoactive elements which may have affected local blood flow. 
If IF microvascular oscillations represent a homeostatic parasympathetically mediated 
response, it is reasonable to hypothesize that maneuvers which increase vagal tone may increase 
the power of these oscillations. One method which has been postulated to affect the 
cardiovascular system via the autonomic nervous system is acupuncture. Investigators have 
shown that acupuncture at different skin locations appears to activate sympathetic or 
parasympathetic responses (or both) to different degrees (65). For example, investigators 
examining the effects of manual acupuncture on LF and HF heart rate fluctuations found that 
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acupuncture at the LI-4 (Hoku) point of the hand elicited both sympathetic and parasympathetic 
responses, while comparable stimulation of the Lung point of the ear (inferior hemi-conchae) 
caused a purely parasympathetic response (65). Therefore, use of an acupuncture technique to 
stimulate the Lung point in a subject may have the potential to enhance the power of any 
parasympathetically-mediated microvascular oscillatory activity that may be occurring. 
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Purpose and Hypothesis 
We believe that there exists a novel homeostatic mechanism in the cutaneous 
microcirculation which is activated in response to a vasoconstrictive stimulus. To provide further 
evidence of this mechanism, and to help characterize it with respect to the possible location or 
locations of the stimulus for its activation, we hope to elicit high-frequency cutaneous 
microvascular oscillatory activity in the forehead via the noninvasive local administration of 
phenylephrine by iontophoresis. In so doing, we hope to replicate the effects seen in the forehead 
following phenylephrine infusion by stimulating the response at a local level. Research has 
already demonstrated that monitoring microvascular oscillatory activity provides information 
about the presence and severity of sympathetic dysfunction, even before clinical signs develop, 
particularly in the setting of diabetes (49,50,51). Having the ability also to monitor a 
parasympathetically-mediated response would expand the value of monitoring cutaneous flow 
periodicity by providing information on the status of both the sympathetic and parasympathetic 
branches of the autonomic nervous system. 
We hypothesize that the iontophoretic delivery of phenylephrine to the forehead skin will 
induce changes in forehead microcirculatory flow similar to those induced by the systemic 
administration of phenylephrine by Silverman and colleagues. Specifically, we anticipate that our 
monitoring of laser Doppler flow in the forehead will reveal changes in spectral components of 
variability indicative of intermediate-frequency (0.12-0.18 Hz) activation and that these changes 
will be specific to the site at which phenylephrine is administered. We further hypothesize that 





The local institutional review board approved the protocol for the present study; all 
subjects gave their informed, written consent. 
The study participants, all healthy nonsmoking males, were instructed to refrain from 
caffeine and other vasoactive substances for several hours prior to each study session. At the 
study’s start, the subject lay recumbent with arms, legs, and head maintained at heart level. The 
room temperature was regulated at 71 ± 1°F. Surface electrodes were applied for monitoring 
ECG and respiration. Two iontophoretic drug delivery pads (Iomed, Inc.) were prepared by 
filling one with 1 ml of 1,600 mcg/ml phenylephrine and the other with 1 ml of 0.9% normal 
saline (NS) diluted 1:6 in sterile water. One laser Doppler flowmetry probe (Periflux 2B, 
Perimed, Sweden) was inserted through each of the two iontophoretic pads, which were then 
affixed to different sites on the subject’s forehead so that the tips of the laser Doppler probes 
rested against the skin, flush with the surfaces of the pads. A third laser Doppler probe was taped 
to a third site on the forehead away from both iontophoresis pads. Thus laser Doppler probes 
were affixed to three forehead sites: a phenylephrine delivery site, a normal saline delivery site, 
and a control site (without an iontophoretic drug delivery pad). A current delivery device was 
attached to each of the two iontophoretic pads, with the positive lead attaching to the drug 
delivery pad and the negative lead connecting to a dispersive pad which was affixed to the 
subject’s upper back. 
During all study phases, the ECG, respiration, and laser Doppler flux were recorded at 
250 Hz with a microprocessor-based system consisting of analog-to-digital converters, 
commercially available data acquisition software (Snapmaster, HEM Data Corp), customized 
software for beat detection and annotation, and commercially available systems for Fourier 
analysis (Snapmaster, HEM Data Corp; Excel, Microsoft). 
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Following the application of our monitoring devices, subjects were allowed to rest 
comfortably for 5-10 minutes before being asked to breathe in synchrony with an audible 
metronome at a rate of 12 breaths per minute (0.2 Hz). Metronome breathing was continued 
throughout the remainder of the study except where otherwise noted. Baseline data were 
collected for a period of 2 minutes. Both iontophoresis current delivery devices were then turned 
on for a period of 10 to 30 seconds at a current of 2 mAmp. Following the period of 
iontophoresis, the subject rested while the investigators monitored the laser Doppler flow patterns 
for the appearance of oscillatory activity and/or a decrease in flow at the phenylephrine site 
indicative of vasoconstriction. If no change in flow was detected at either site after 5 additional 
minutes of recording, iontophoresis was repeated at both sites for an additional 10 to 30 seconds, 
after which flow was again monitored for 5 minutes. This sequence was repeated as necessary 
until a maximum total duration of iontophoresis of 2 minutes was reached. 
When a >10% decrease in flow at the phenylephrine forehead site became evident, the 
subject was allowed to rest for approximately 10 minutes. After this rest period, an investigator 
applied manual fingertip acupressure to the Lung point (inferior hemi-conchae) of both of the 
subject’s ears for a period of 2 minutes, after which the subject was allowed to rest for an 
additional 2 minutes. 
Analysis 
The frequency and power of the laser Doppler flux signals were characterized by auto¬ 
power spectral density (APSD) frequency-domain analysis. The computer resampled the laser 
Doppler flux signals at 5 Hz, a rate, according to Nyquisf s Theorem (66), more than sufficient to 
enable identification of oscillatory frequencies within our range of interest (0.05-0.30 Hz). We 
then selected multiple segments ranging from 2 to 3 minutes from each of the three laser Doppler 
site tracings and from these generated sets of APSDphenyi, APSDns, and APSDcontroi in each subject 
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using a traditional Parzan window, Gaa = [ave(SaS*a)]/df, wherein Gaa is instantaneous amplitude 
spectral density of channel a, Sa is instantaneous amplitude spectrum of channel a, S*a is complex 
conjugate of Sa, and df is frequency resolution (0.005 Hz). The laser Doppler flux time segments 
selected for frequency domain analysis at each site were as follows: 1) baseline; 2) during 
maximal vasoconstriction at the phenylephrine site; 3) during the period of maximum IF range 
oscillatory power for each site (after iontophoresis but before ear acupressure); 4) during ear 
acupressure; 5) immediately after ear acupressure. Thus the analyzed time segments represent 
simultaneous recordings at all three laser Doppler sites with the exception of the “maximum IF 
range oscillatory power” phase, which was selected as the period of maximum IF oscillations at 
each site. 
After the flux tracings from each forehead site and time segment had been characterized 
by Fourier analysis, for each APSD the 0.01-Hz wide bin with maximum power (“maxbin”) in 
the IF range was identified. The IF range maxbin power at all three sites was compared, for all 
studies, using one-way analysis of variance (ANOVA). A paired t-test was then used to compare, 
for all studies, the IF range maxbin power at the phenylephrine site versus that at the normal 
saline site and at the phenylephrine site versus the control site. 
In addition to comparing the maxbin power at the phenylephrine site with that of the 
other sites, we compared the maxbin power during each time segment with the power at baseline 
to quantify the overall change in maxbin power. Dividing the maxbin power at each segment by 
the baseline power proved to be an unreliable technique because the baseline powers, while 
generally negligible, varied enough (0.01-0.07 at the phenylephrine site) to cause excessive 
distortion of such ratios. We therefore decided to quantify changes in maxbin power in the 
following two ways. First, for each forehead site we calculated the maxbin power at each phase 
minus the power at baseline. Additionally, we used a paired t-test to compare, for each forehead 
site, the maxbin power during each time segment with the power at baseline. 
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One study was selected for analysis of the beat-to-beat percent change in flux. Using 
software for detection of R waves on the ECG tracing, the laser Doppler flux during each 
heartbeat was recorded. The percent change in flux from one beat to the next was calculated 
using the formula [((n2-ni)/ni)* 100] where ni represents the laser Doppler flux at one heartbeat 
and n2 represents the flux at the subsequent beat. 
In four of the studies, the time-domain indices of the heart rate and R-R interval (the time 
in milliseconds between two consecutive R-waves as measured by an ECG) were reported as 
mean ± standard deviation. For each time segment, the ECG tracing itself was also sampled at 
250 Hz, resampled at 5 Hz, then characterized by APSD analysis. The IF range maxbin power of 




The forehead site which received iontophoresed phenylephrine showed an average 25% 
decrease in flux following iontophoresis. By contrast, after iontophoresis the NS site showed 
either no change in flux or a mild increase, while flux at the control site did not change markedly. 
The phenylephrine site showed an increase in IF range maxbin oscillatory power at 
approximately 0.125 Hz during the phase of ear acupressure, which was significant compared 
with the other forehead sites and with the phenylephrine site during the baseline period. No 
consistent change was seen throughout the study in R-R interval, R-R variability, or IF maxbin 
power of the heart rate. 
Figure 1 shows a representative example of raw data collected during a study. The top 
portion of the figure portrays the two-minute baseline period, while the bottom portion displays 
the two-minute period during ear acupressure. Shown for each segment are the ECG tracing, 
laser Doppler tracings for the forehead phenylephrine and control sites, and the respiratory 
monitor tracing. The small rises and falls in flux represent downstream transmission of each 
cardiac systolic contraction. In addition, periodic oscillations in flux can be seen most 
prominently at the phenylephrine site during ear acupressure, where they show a frequency of 
approximately seven per minute. 
Figure 2 shows the mean laser Doppler flux measured at each of the three forehead sites 
for each study during the five time periods of interest. Although the “maximum 
vasoconstriction” phase, shown for all three sites, is based on the period of lowest flux at the 
phenylephrine site alone, there were no obvious periods of increase or decrease in flux at the 
other two forehead sites that are not reflected by the values plotted in Figure 2. Table 1 shows the 
mean flux over all studies at each site during each time period. Also given in this table are p 
values for a two-tail paired t-test comparing, for each site, the mean flux during each phase with 
the mean flux at baseline. Because of the skewness of the data, the flux values were also 
compared by a two-tail paired t-test after In (natural log) transformation, which helps correct for 
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wide variability of a few single data points. These p values are also shown in Table 1. In 
addition, because multiple t-tests were performed on the same set of data, Bonferroni’s method 
was used to adjust the level of significance in order to reduce the probability of type I error (67). 
p values indicating significance after Bonferroni’s adjustment are indicated in the table with an 
asterisk. 
As expected, there is a significant decrease in flux (approximately 25%) at the 
phenylephrine site following iontophoresis (which occurred between the phases of baseline and 
maximum vasoconstriction), indicating local vasoconstriction {p = 0.001-0.007). The 
significance of this decrease in flux at the phenylephrine site is maintained after In 
transformation. By contrast, no significant change in flux is seen at the control site, consistent 
with there being no systemic effect of the phenylephrine. The variable increase in flux at the 
normal saline site in several subjects indicates a potential hyperemic effect from iontophoresis 
itself; this resulted in an overall increase in flux at the NS site during ear acupressure. Althoughp 
values for the uncorrected data indicate a significant change in flux at the NS site during and after 
ear acupressure when compared with baseline, no subject developed vasoconstriction at the NS 
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Fig. 2: Mean laser Doppler flux for all studies. 
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Table 1: Mean (standard error of mean) flux for all studies 
Baseline Maximum Maximum Ear Post- 
vasoconstriction oscillations acupressure acupressure 
Phenylephrine 
P 
p (In trails) 
Normal saline 
P 
p (In trans) 
Control site 
P 








































Data values indicate the mean flux for all eight studies at the given forehead site and time 
period, p values are for two-tail paired t-test comparing the flux during each time period 
versus the flux at baseline. The first p value in each set represents comparison of the 
actual flux values between the given phase and baseline; the second p value represents 
comparison after In transformation of the flux values for the given phase and baseline in 
order to minimize the influence of skewness, p values retaining significance after 
Bonferroni’s adjustment are indicated with an asterisk. 
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Figure 3 shows APSDphenyi, APSDNs, and APSDcontroi during the baseline time period of 
the study for which the raw data is shown in Figure 2. Also shown is the beat-to-beat percent 
change in flux at all three laser Doppler sites during the baseline time period. Figures 4, 5, and 6 
illustrate this same set of data during the following time periods: maximum vasoconstriction at 
the phenylephrine site, ear acupressure, and immediately following ear acupressure, respectively. 
As can be seen by comparing the figures, the APSD of the phenylephrine site develops a 
prominent peak at 0.125 Hz during the phases of ear acupressure and post-acupressure, while the 
other two sites do not develop as much oscillatory power in the IF range (0.12-0.18 Hz). 
Examining the tracings of beat-to-beat percent change reveals an increased organization of the 
beat-to-beat changes in flux at the phenylephrine site during and after acupressure compared with 
the other forehead sites and with the phenylephrine site before acupressure. 
Figure 7 plots the values of IF range maxbin power for each study. Reviewing the 
graphs, a marked increase in IF maxbin power is noted in almost all subjects during the post¬ 
iontophoresis period, ear acupressure, or both. By contrast, with the exception of one subject at 
the NS site, there is no obvious change in the IF maxbin power at either the NS or control site. 
For each of the five study phases, the IF maxbin power was compared between all three sites 
using ANOVA. Because of the appearance of several potentially outlying data points, the data 
was corrected for skewness by taking the natural log (In) of each maxbin power. By ANOVA, a 
significant difference exists between the maxbin powers at the three sites during the ear 
acupressure and post-acupressure phases (p = 0.0009 and p = 0.036, respectively, for In 
transformation corrected data). 
Table 2 presents, for each forehead site and time segment, the mean maxbin power over 
all studies. Included in this table arep values for a two-tail paired t-test comparing, for all 
studies, the maxbin power at the phenylephrine site versus the NS site and at the phenylephrine 
site versus the control site, p values for a paired t-test comparing the In transformation of the 
maxbin power at the phenylephrine site versus the NS site and at the phenylephrine site versus the 
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control site are also presented in the table. The p values in Table 2 indicate the development of a 
significantly greater IF maxbin power at the phenylephrine site compared with the other two sites 
during the phases of ear acupressure and post-acupressure (p < 0.05 versus both NS and control 
sites during both of these time periods). A t-test comparing the In transformation of the maxbin 
powers during the acupressure phase shows even greater significance than when comparing the 
actual maxbin powers. Therefore, correcting for skewness in the data by using In transformation 
increases the significance of the acupressure-phase IF oscillatory power at the phenylephrine site 
compared with the NS and control sites. 
Figure 8 plots, for each study, the maxbin power during each phase minus the maxbin 
power during the baseline phase (phase-minus-baseline). Table 3 presents, for each forehead site 
and time segment, the mean phase-minus-baseline value over all studies. Included in this table 
are p values for a two-tail paired t-test comparing, for all studies, phase-minus-baseline at the 
phenylephrine site versus the NS site and at the phenylephrine site versus the control site. These 
p values indicate a significantly greater phase-minus-baseline power at the phenylephrine site 
versus both the NS and control sites during the period of ear acupressure. Because several of the 
phase-minus-baseline power values are negative (indicating a higher oscillatory power at baseline 
than during a later phase), In transformation is not possible for this set of data. 
Table 4 displays p values for a paired t-test comparing, over all studies, the IF maxbin 
power during each phase with the IF maxbin power at baseline. 
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Beat-to-Beat Percent Change in Flux at Baseline 
Time (seconds) 




Beat-to-Beat Percent Change in Flux at Maximum Vasoconstriction 
Time (seconds) 
Fig. 4: APSDphenyi, APSDns, APSDcontroi, and beat-to-beat percent change in flux during 
period of maximum vasoconstriction at the phenylephrine site. 
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Beat-to-Beat Percent Change in Flux During Ear Acupressure 
Time (seconds) 
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Fig. 7: IF range (0.12-0.18 Hz) maxbin power for all studies at phenylephrine, nonnal 
saline, and control sites. 
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Phenylephrine 0.024 (0.009) 0.061 (0.023) 0.070 (0.022) 0.100 (0.032) 0.140 (0.050) 
Normal saline 0.016(0.008) 0.041 (0.019) 0.043 (0.019) 0.028 (0.015) 0.019(0.005) 
P 0.5 0.5 0.3 0.010* 0.043 
p (In trans) 0.1 0.9 0.3 0.005* 0.033 
Control site 0.026 (0.013) 0.030 (0.009) 0.037 (0.010) 0.008 (0.003) 0.020 (0.006) 
P 0.9 0.3 0.2 0.025* 0.046 
p (In trans) 0.6 0.8 0.4 0.002* 0.056 
Data values indicate the mean maxbin power for all eight studies at the given forehead 
site and time period, p values are for two-tail paired t-test comparing normal saline site 
vs. phenylephrine site and control site vs. phenylephrine site. The first p value in each set 
represents comparison of the actual maxbin powers between the two sites; the second p 
value represents comparison after In transformation of the maxbin powers for each site in 
order to minimize the influence of skewness, p values retaining significance after 
Bonferroni’s adjustment are indicated with an asterisk. 
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Phenylephrine Site Maxbin Power, 0.12-0.18 Hz 
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Normal Saline Site Maxbin Power, 0.12-0.18 Hz 
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Control Site Maxbin Power, 0.12-0.18 Hz 
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—■— Study 2 
Study 3 
—X— Study 4 
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minus baseline baseline 
Fig. 8: IF maxbin power, phase-minus-baseline. Data points represent IF maxbin 
power at given phase minus IF maxbin power at baseline. 
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Table 3: IF (0.12-0.18 Hz) maxbin power, phase minus baseline: mean (standard error of 









Phenylephrine 0.037 (0.017) 0.046 (0.015) 0.076 (0.035) 0.116(0.051) 
Norm saline 0.025 (0.022) 0.028 (0.022) 0.012 (0.019) 0.003 (0.009) 
P 0.6 0.4 0.045 0.053 
Control site 0.004 (0.010) 0.012 (0.010) -0.017(0.011) -0.005 (0.008) 
P 0.2 0.2 0.029 0.053 
Data values indicate the mean of (maxbin power at indicated phase minus maxbin power 
at baseline) for all eight studies, p values are for two-tail paired t-test comparing normal 
saline site vs. phenylephrine site and control site vs. phenylephrine site. No p value 
retained significance after Bonferroni’s adjustment. 

33 










P 0.063 0.019 0.063 0.058 
p (In trans) 0.4 0.022 0.008* 0.040 
Norm saline 
P 0.3 0.3 0.5 0.7 
p (In trans) 0.08 0.08 0.4 0.1 
Control site 
P 0.7 0.3 0.2 0.5 
p (In trans) 0.3 0.043 0.4 0.3 
p values are for two-tail paired t-test comparing the IF maxbin power during each time 
period versus the IF maxbin power at baseline. The first p value in each set represents 
comparison of the actual maxbin powers between the given phase and baseline; the 
second p value represents comparison after In transformation of the maxbin powers at 
each phase in order to minimize the influence of skewness, p values retaining 
significance after Bonferroni’s adjustment are indicated with an asterisk. 
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Figure 9 plots the mean R-R interval over four time phases for four studies. The 
“maximum oscillations at each site” phase is omitted from this plot because this phase was 
different for each of the three forehead sites and therefore did not correlate with one specific ECG 
time segment. Also shown in this figure is the standard deviation of the R-R interval in the same 
four studies. Based on the R-R interval plot, there was no consistent change in R-R interval 
during the course of each study. In particular, there is no obvious increase in R-R interval during 
the ear acupressure phase, suggesting that there was no systemic vagal effect from acupressure. 
There was also no consistent change in the variability of the R-R interval, as shown by the plot of 
standard deviation. 
Figure 10 displays the IF range maxbin power of the heart rate for four studies. The 
“maximum oscillations at each site” phase is omitted from this plot for the same reason as in 
Figure 9. Only one subject showed an obvious change in IF range maxbin heart rate power, 
which occurred during the acupressure phase. This subject did not evidence an unusually high IF 
power at the phenylephrine site, arguing against transmission of these oscillations from the heart. 
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Mean R-R Interval for 4 Studies 




Fig. 9: Mean R-R interval and standard deviation of R-R interval for four studies. 
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The results of this investigation include several interesting findings regarding 
microvascular cholinergic oscillatory control. We have shown that iontophoretic administration 
of phenylephrine, when accompanied by an acupressure method known to increase vagal tone, 
precipitated an increase in the organization and amplitude of oscillatory activity in the forehead 
microvasculature at a frequency believed to be incompatible with a sympathetic-mediated 
oscillatory process (i.e., greater than 0.12 Hz). This frequency was also shown to be different 
from the metronome-controlled respiratory frequency and from heart rate variability. 
Furthermore, in this study these oscillations appeared in the setting of an average decrease in 
local microvascular flux of 25% due to the phenylephrine. The present study offers at least three 
major contributions to current investigations of microvascular cholinergic oscillatory control. 
First, this study adds to the understanding of the physiology of microvascular oscillatory 
activity. Prior studies by Silverman and colleagues demonstrated that systemic administration of 
phenylephrine elicited forehead microvascular oscillations in the IF range (0.12-0.18 Hz) and that 
these oscillations were distinct from the respiratory frequency and from heart rate variability 
(35,42). However, although these studies separated the microvascular oscillations from known 
systemic forms of periodicity, they did not address whether these oscillations could still be 
mediated in part by baroreceptor activity, nor did they attempt to localize the components of the 
reflex in terms of “afferent” or “efferent” limbs. Although the entire pathway (or pathways) 
remains to be delineated, the current study provides evidence against a baroreceptor-mediated 
mechanism. 
There appear to be two basic components of the microvascular reflex seen in this study. 
The first component is the vasoactive challenge (phenylephrine), as evidenced by the IF range 
oscillations being significantly more powerful at the phenylephrine site than at the NS or control 
sites during the ear acupressure phase. The second component is the acupressure, which we 
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believe, in agreement with other investigators’ findings, led to an increase in vagal output (65). 
With the introduction of ear acupressure, the phenylephrine and NS sites, which had previously 
behaved similarly in response to their respective iontophoretic stimuli, suddenly showed 
significant differences in their IF range maxbin oscillatory powers. Thus, we have shown that IF 
range microvascular oscillations can be elicited at a local skin site by administering a 
vasoconstrictive challenge specifically at that site and enhancing vagal output with acupressure. 
Although this finding is a significant step forward from the prior investigation using systemic 
phenylephrine, we cannot yet conclude that the entire oscillatory reflex is mediated locally. We 
have demonstrated that the iontophoresed phenylephrine produced no systemic effects, as 
evidenced by there being no change in flux at the control site and no consistent change in the R-R 
interval or in R-R variability. However, given that acupressure was required to elicit the 
oscillatory activity fully, we cannot yet rule out a central component to the pathway. 
As its second major contribution, this study serves as a model which enhances our current 
understanding of the mechanism of acupuncture. In this study acupressure (a form of 
acupuncture) was required to elicit fully the local IF microvascular oscillatory effect. While this 
finding initially came as a surprise to our team, it is consistent with the current knowledge of how 
acupuncture works. Acupuncture is a much-studied but incompletely understood technique 
which has been used for over 4,000 years to treat pain as well as a wide variety of medical 
diseases ranging from asthma to gastrointestinal disorders to mood disorders (70,71). Based on 
the traditional Chinese principle of opposites and the dynamic balance of the two opposing 
forces, Yin and Yang, acupuncture has long been considered a technique which works by 
restoring balance to a biological system whose homeostasis has been disturbed by a disease 
process (70,72). A complete discussion of the many current biological theories of how 
acupuncture may exert its effects is beyond the scope of this paper. However, common to many 
of the theories is that acupuncture has little or no effect on normal function; rather, “only in 
dysfunction does the ’balancing mechanism’ produce clear effects” (72). In light of this 

39 
understanding, it seems reasonable to view the three laser Doppler forehead sites in terms of any 
imbalances in blood flow which may have been imposed on them during the study. The control 
site received no direct stimulation and, as expected, showed no significant change in its IF range 
maxbin power throughout the study. The NS site underwent iontophoresis, which led to a 
variable mild increase in flux in some subjects but did not result in a significant change in IF 
maxbin power. The phenylephrine site, however, showed evidence of vasoconstriction based on 
an average 25% decrease in flux following iontophoresis. It was at this site, where blood flow 
homeostasis was most greatly disturbed, that the IF maxbin power increased significantly during 
acupressure. In other words, we propose that the phenylephrine forehead site alone was primed, 
by a vasoconstrictive challenge, to respond to the acupressure-induced increase in vagal tone 
which mediated the homeostatic oscillatory response. Although the exact chemical nature of this 
‘■‘priming” is unknown, one possibility is that the vasoconstriction leads to an increased local 
concentration of acetylcholine, which is then present to exert its cholinergic homeostatic effect 
with the increase in vagal tone. 
This analysis suggests that in our study, phenylephrine-induced vasoconstriction created 
the type of blood flow imbalance which microvascular oscillations may exist to offset. However, 
several differences between these results and those seen in an earlier study involving systemic 
administration of phenylephrine call for an explanation. The IF range forehead microvascular 
oscillations Silverman and colleagues observed upon intravenous infusion of phenylephrine were 
neither accompanied by nor preceded by any change in forehead flux (35). Additionally, the 
oscillations were seen without any additional stimuli such as acupressure. These two major 
differences between the studies, if considered together, may help to explain each other. Although 
local tissue concentrations of phenylephrine were not measured in either study, the 25% decrease 
in forehead flux in the present study suggests a higher local drug concentration at the forehead 
phenylephrine site than may have existed when phenylephrine was administered systemically 
with no change in forehead flux. If so, it is quite possible that the vasoconstriction induced by the 
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iontophoresed phenylephrine was greater than the physiological imbalances that microvascular 
oscillations may exist to offset. The compensatory system may initially have been overwhelmed 
by the local phenylephrine concentration, and not until parasympathetic tone was increased by ear 
acupressure was the homeostatic response able to exert a measurable effect. By contrast, with 
systemic infusion of phenylephrine, the local forehead drug concentration may have created a 
vasoactive challenge more similar to normal physiological imbalances, i.e., just enough to 
activate the homeostatic oscillatory response, which in turn prevented a significant decrease in 
local flow. 
Another difference between the two studies lies in the route taken by phenylephrine to 
reach the microvasculature. When infused intravenously, the phenylephrine began at the lumenal 
aspect of the microvasculature and from there traveled to its effector site(s). However, the 
iontophoresed phenylephrine passed through cutaneous and subcutaneous tissue, reaching the 
outer component of the vessels first. Without a full knowledge of the receptors and effector sites 
involved in the oscillatory pathway, we cannot yet describe how the system is affected by the 
route of drug travel. Nevertheless, these differences between methods of administration should 
be kept in mind during future studies, as they may help to explain any differences in the 
oscillatory effect, particularly in the time course of the response. 
The third major potential contribution of this study is toward the development of a 
method of monitoring and testing cholinergic oscillatory control of the microvasculature in the 
clinical setting. The interest in such a technique stems from multiple investigations which have 
shown that autonomic dysfunction is responsible for considerable morbidity and mortality among 
patients with cardiovascular diseases such as diabetes and hypertension (66,68). There has been 
recent interest in the monitoring of microcirculatory oscillations as a method of detecting 
autonomic dysfunction in patients before it becomes clinically apparent (50,51). In fact, several 
investigators have not only demonstrated impairment of sympathetic-frequency microvascular 
oscillations in diabetic patients, but also have shown that the degree of impairment correlates with 
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the duration of diabetes, the resting heart rate variability, and the median motor and sensory nerve 
conduction velocities (50,51,52). Adding to these tests of sympathetic dysfunction, the ability to 
detect the presence or absence of a parasympathetic microvascular homeostatic response to 
vasoconstriction would enable the testing of both divisions of the autonomic nervous system and 
thereby increase the flexibility and sensitivity of such testing. The next critical step in the 
development of this form of testing is to assess whether patients with advanced diabetes show 
evidence of IF range microvascular oscillations in response to a vasoconstrictive challenge. 
One major limitation of the present study is that the laser Doppler probe shows variability 
in its absolute flux measurements at different forehead skin sites in the same subject. These 
variations are presumably due to site-dependent differences in the microvascular anatomy 
beneath the probe (69). We have attempted to overcome this problem in several ways. When 
determining the significance of changes in flux measured by each probe, we compared the flux 
during each phase with the flux at baseline so that changes would be detected at each site 
regardless of differences between probes in the measurement of absolute flux. In addition, we 
examined the beat-to-beat percent change in flux for each phase of interest rather than 
considering only absolute flux. Finally, when evaluating maxbin oscillatory power (which is 
affected by absolute flux), we examined changes in power over time and, for each forehead site, 
compared the maxbin power at each phase with the power at baseline. 
A second limitation of this study is that we have not yet confirmed the cholinergic nature 
of the microvascular oscillations by administering atropine (as had been done with intravenous 
phenylephrine). However, having now demonstrated the development of IF range microvascular 
oscillations within minutes after iontophoresis, followed by their enhancement with acupressure 
ten minutes after iontophoresis, we feel better prepared to administer atropine having some 
knowledge of the time course of the oscillatory effect. Additionally, the observed oscillations 
show a frequency that is outside the range within which the sympathetic nervous system is 
believed to be capable of mediating, providing indirect evidence of their parasympathetic nature. 
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Thus the present study has contributed to the understanding of the physiology of 
microvascular oscillatory activity, to the theories regarding the mechanism of acupuncture, and to 
the potential development of a clinical test for autonomic dysfunction. Further studies will 
include the administration of atropine, which we hope will provide further evidence of a 
parasympathetic mediation of the IF microvascular oscillations. Additionally, studies involving 
patients with known advanced diabetes will reveal whether such patients have lost this 
compensatory mechanism. The utility of a clinical test for both sympathetic and parasympathetic 
dysfunction, as well as the potential for characterizing a previously unrecognized homeostatic 
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